Latest Breaking News On - Abi jain - Page 1 : comparemela.com

Aytu BioPharma, Inc (NASDAQ:AYTU) Q4 2023 Earnings Call Transcript

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call Transcript September 27, 2023 Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2023 Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now […]

United statesAytu biopharmaAytu rxconnectNaz rahmanAbi jainMark okiJosh disbrowVenture opportunities fundConsumer healthMaxim groupChief executive officerCotempla prior approval supplementNantahala capital managementAvenue venture opportunities fundGrant thorntonPublic transportation

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRoger weissAytu biopharmaAbhinav jainMark okiAbhinav abi jainAytu biopharma incNantahala capital managementVenture opportunities fundMaxim groupCompany board of directors upon closingCompany board of directorsExchange commissionDirectors uponCommon warrants

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
clevelandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clevelandstar.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMark okiAbhinav abi jainAytu biopharmaRoger weissAbhinav jainNantahala capital managementCompany board of directors upon closingMaxim groupVenture opportunities fundAytu biopharma incCompany board of directorsExchange commissionDirectors uponCommon warrants

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
stlouisstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stlouisstar.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMark okiAbhinav abi jainAbhinav jainAytu biopharmaRoger weissNantahala capital managementCompany board of directors upon closingExchange commissionCompany board of directorsAytu biopharma incMaxim groupVenture opportunities fundDirectors uponCommon warrants

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Closing of $4 0 Million Public Offering Priced At-the-Market
dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMark okiAbhinav jainRoger weissAbhinav abi jainAytu biopharmaVenture opportunities fundCompany board of directorsExchange commissionNantahala capital managementCompany board of directors upon closingMaxim groupAytu biopharma incDirectors uponCommon warrants